Observational Study of Patients Undergoing Diagnostic Right Heart Catheterization (NCT07224906)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (1 Sites)

• Boulder Heart — Boulder, Colorado

📞 Contact the Study Coordinator

Phone: (303) 442-2395

Email: kathari.adkins@bch.org

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Pulmonary Hypertension

• Trans-pulmonary Biomarkers in Pulmonary Hypertension — Nashville, Tennessee
• Activity Monitoring in Pulmonary Hypertension — Nashville, Tennessee
• LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF — Tucson, Arizona
• A Study of TX000045 in Patients With Pulmonary Hypertension Secondary to Heart Failure With Preserved Ejection Fraction (the APEX Study) — Phoenix, Arizona
• A Study of Mosliciguat in PH-ILD — Phoenix, Arizona
• Frespaciguat (MK-5475) INSIGNIA-PH-COPD: A Study of the Efficacy and Safety of Frespaciguat (an Inhaled sGC Stimulator) in Adults With PH-COPD — San Francisco, California

Explore by condition: All Pulmonary Hypertension clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Contact the study coordinator using the phone/email above.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.